Clinical Trial Update: Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating acceptability and feasibility of injectable cabotegravir PrEP versus oral PrEP in routine care at private pharmacies in South Af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir injectable (cabotegravir)
• emtricitabine/tenofovir disoproxil fumarate (oral PrEP) (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: HIV Infections | Phase 3 | Status: ACTIVE_NOT_RECRUITING